Policy Implementation

Under the Consolidated Appropriation Act of 2016, federal law permits use of funds from the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) to support syringe access - with the exception that funds may not be used to purchase syringes or cookers. In order to use federal funds for this purpose, health departments must first consult with CDC and provide evidence that their jurisdiction is experiencing or at risk for significant increases in hepatitis infections or an HIV outbreak due to injection drug use.

Thirty states and 7 jurisdictions received this Determination of Need Justification from the CDC as of December 12, 2017, yet the redirection and utilization of these federal funds continues to be a challenge in many states.

Free Training and Technical Assistance (TA) 

Whether you need help with the Determination of Need Process, implementing new syringe access programs, or strengthening existing syringe access, capacity-building and technical assistance is available cost-free to community-based groups and health departments. Training and TA will increase your skills, infrastructure, and resources to help your organization operate optimally to deliver high quality and effective syringe access programs.



Community-based organizations may be eligible for free technical assistance on how to implement syringe access or support your existing program. Both AIDS United and Harm Reduction Coalition can provide assistance to your organization through the Getting to Zero training request form here.




NASTAD works with health department HIV and hepatitis programs and provides capacity -building assistance and TA around creating, implementing, and supporting health department and community-based syringe access programs.



Discover national, statewide, and district-based information from amfAR's Opioid & Health Indicators Database.

October 2015 Congressional Briefing

On October 28th, 2015, the Coalition for Syringe Access hosted two panel discussions on pathways to reduce the transmission of HIV and Hepatitis C (HVC) among people who inject drugs. The panel brought together experts on disease transmission, prevention and recovery and law enforcement who highlighted opportunities to strengthen partnerships between public health and public safety programs to reduce infection rates.


Sign-on Letter to congress on Syringe Access 


Press Release on the Congressional Briefings